CYCN: Cyclerion Therapeutics Company Short-Term Debt
The market valuation chart for Cyclerion Therapeutics (CYCN), which develops solutions for treating nerve disorders, demonstrates the 0.00 metric. The business relies on seamless collaboration with global contract research organizations for drug trials. This strategy minimizes capital expenditures in favor of an in-house development team. However, geopolitical instability and sanctions could disrupt component logistics and jeopardize international testing timelines.
CYCN (Cyclerion Therapeutics Inc.): analytical breakdowns and indicator data
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
- net income and valuation multiples indicators:
Fundamental company valuation:cyclerion.com (CYCN)
When selecting issuers, fundamental analysis relies on the ratio of liabilities to liquidity to assess financial stability. This metric measures accounts payable with a maturity of up to one year, which is critical for Cyclerion Therapeutics (CYCN) when financing the development of CNS drugs; therefore, the short-term debt chart helps determine the risk of funding shortages or excessive debt leverage during the innovative drug creation stage.
Main competitors
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Current Liabilities xenon-pharma.com (XENE)|Company Current Liabilities VKTX (Viking Therapeutics, Inc.)|SUPN - Short-Term Debt|Company Short-Term Debts CPRX (Catalyst Pharmaceuticals Inc)|DNLI - Company Current Liabilities|HRMY - Company Short-Term Debt|BHVN: Company Short-Term Debt|AMLX: Company Short-Term Debts|Short-Term Debt Trevi Therapeutics Inc (TRVI)|Company Short-Term Debt Praxis Medicines|AVXL: Company Short-Term Loans and Borrowings|Company Short-Term Debts CBLL|Short-Term Debt Volume Prothena Corporation plc|Company Short-Term Debt Alector ALEC|Annexon Biosciences (ANNX) - Short-Term Debt|OMER - Company Short-Term Debt|NGNE (Neurogene Therapeutics) - Company Short-Term Indebtedness|ACIU (AC Immune) - Company Current Liabilities|voyagertherapeutics.com - Company Short-Term Loans and Borrowings|Company Current Liabilities NMRA|SCLX (Scilex Holding) - Amount of Current Liabilities|Company Short-Term Debts TVGN|ACOG (alphacognition.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|inhibikase.com (IKT) - Short-Term Debt|SAVA - Company Short-Term Debt|Company Short-Term Loans and Borrowings ASRT (Assertio Holdings, Inc.)|COYA: Company Short-Term Debts|Vistagen (VTGN) - Company Short-Term Debts|Company Short-Term Debt Ovid Therapeutics Inc|acumenpharm.com - Current Liabilities|Company Short-Term Debts CRVO|ATHE - Short-Term Debt|Clene - Company Current Liabilities|Company Short-Term Debts PepGen Inc PEPG|JUNS: Company Current Liabilities|relmada.com - Amount of Current Liabilities|ANVS: Company Short-Term Debts|GRCE - Short-Term Debt Volume|AIFF (Firefly Neuroscience Inc) - Company Short-Term Debts|Company Current Liabilities ANEW Medical, Inc. (KLTO)|Company Short-Term Debt NeuroSense Therapeutics (NRSN)|Short-Term Debt Volume revivapharma.com|Company Short-Term Debts MTVA (MetaVia)|NRXS - Company Current Liabilities|HSDT: Company Current Liabilities|Short-Term Debt Passage Bio, Inc.|NEUP: Company Short-Term Debts|Company Current Liabilities minervaneurosciences.com|Company Short-Term Debt Athira Pharma|Company Short-Term Indebtedness ADXN (Addex Therapeutics Ltd.)|Company Short-Term Debt Alzamend Neuro, Inc. (ALZN)|protagenic.com - Company Short-Term Indebtedness|Company Short-Term Debts KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc (CRGT) - Short-Term Debt|ATXI: Company Current Liabilities|BCLI - Company Short-Term Debts|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|Chromocell - Company Short-Term Loans and Borrowings|Company Short-Term Debt Eliem Therapeutics, Inc.|Short-Term Debt Intra-Cellular ITCI|Company Short-Term Debts LBPH|Company Current Liabilities Marinus Pharmaceuticals Inc MRNS|NKGen - Company Current Liabilities|NeuroBo Pharma (NRBO) - Short-Term Debt|Sage Therapeutics, Inc. - Company Short-Term Debts|synaptogen.com (SNPX) - Company Current Liabilities|Trevena (TRVN) - Company Short-Term Debt|VIGL (Vigil Neuroscience, Inc.) - Company Short-Term Debt|WENA (Anew Medical, Inc.) - Company Short-Term Debts|Short-Term Debt Cerevel Corp CERE